Stephen A Rappaport

Summary

Publications

  1. ncbi A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia
    Stephen A Rappaport
    Agewell Health, Indianapolis, IN 46260, USA
    J Am Med Dir Assoc 10:21-7. 2009
  2. ncbi Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia
    Walter G Deberdt
    Lilly Research Laboratories, Indianapolis, IN, USA
    Am J Geriatr Psychiatry 13:722-30. 2005

Detail Information

Publications2

  1. ncbi A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia
    Stephen A Rappaport
    Agewell Health, Indianapolis, IN 46260, USA
    J Am Med Dir Assoc 10:21-7. 2009
    ..To evaluate the tolerability of intramuscular (IM) aripiprazole in patients with agitation associated with dementia...
  2. ncbi Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia
    Walter G Deberdt
    Lilly Research Laboratories, Indianapolis, IN, USA
    Am J Geriatr Psychiatry 13:722-30. 2005
    ..The authors compared efficacy of olanzapine versus placebo and risperidone as measured by the Neuropsychiatric Inventory and Clinical Global Impression-Severity of Psychosis scale in patients with dementia-related psychosis...